Clinical Trial Update: Low Dose Oral Methotrexate in Pediatric Crohn's Disease Patients Initiating Anti-Tumor Necrosis Factor (Anti-TNF) Therapy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating low-dose oral methotrexate combined with anti-TNF therapy in pediatric Crohn's disease; study completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Anti-TNF therapy
• Methotrexate (low-dose oral) (methotrexate)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Pediatric Crohn's Disease | Phase 3 | Status: COMPLETED | Results posted: 2023-04-12